P
Paul Schoenhagen
Researcher at Cleveland Clinic
Publications - 343
Citations - 22058
Paul Schoenhagen is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Coronary artery disease & Intravascular ultrasound. The author has an hindex of 60, co-authored 329 publications receiving 20473 citations. Previous affiliations of Paul Schoenhagen include Medtronic plc & Cleveland Clinic Lerner College of Medicine.
Papers
More filters
Journal ArticleDOI
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial
Steven E. Nissen,E. Murat Tuzcu,Paul Schoenhagen,B. Greg Brown,Peter Ganz,Robert A. Vogel,Tim Crowe,Christopher J. Cooper,Bruce R. Brodie,Cindy L. Grines,Anthony N. DeMaria +10 more
TL;DR: For patients with coronary heart disease, intensive lipid-lowering treatment with atorvastatin reduced progression of coronary atherosclerosis compared with pravastatin.
Journal ArticleDOI
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Steven E. Nissen,Stephen J. Nicholls,Ilke Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie A. Cain,Kathy Wolski,Marlene Goormastic,E. Murat Tuzcu +15 more
TL;DR: In this paper, the authors evaluated the effect of rosuvastatin on coronary atheroma burden using intravascular ultrasound (IVUS) imaging. And they found that very intensive statin therapy could regress coronary atherosclerosis as determined by IVUS imaging.
Journal ArticleDOI
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
Steven E. Nissen,Taro Tsunoda,E. Murat Tuzcu,Paul Schoenhagen,Christopher J. Cooper,Muhammad Yasin,Gregory M. Eaton,Michael A Lauer,W. Scott Sheldon,Cindy L. Grines,Stephen H. Halpern,Tim Crowe,James C. Blankenship,Richard A. Kerensky +13 more
TL;DR: A recombinant ApoA-I Milano/phospholipid complex administered intravenously for 5 doses at weekly intervals produced significant regression of coronary atherosclerosis as measured by IVUS, and results require confirmation in larger clinical trials with morbidity and mortality end points.
Journal ArticleDOI
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
Steven E. Nissen,E. Murat Tuzcu,Paul Schoenhagen,Tim Crowe,William J. Sasiela,John Tsai,John Orazem,Raymond D. Magorien,Charles O'Shaughnessy,Peter Ganz +9 more
TL;DR: For patients with coronary artery disease, the reduced rate of progression of atherosclerosis associated with intensive statin treatment, as compared with moderate statin Treatment, is significantly related to greater reductions in the levels of both atherogenic lipoproteins and CRP.
Journal ArticleDOI
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis
Anuja Nair,Barry D. Kuban,E. Murat Tuzcu,Paul Schoenhagen,Steven E. Nissen,D. Geoffrey Vince +5 more
TL;DR: Coronary plaque composition can be predicted through the use of IVUS radiofrequency data analysis, and autoregressive classification schemes performed better than classic Fourier methods, enabling in vivo plaque characterization.